Date:
10^th November 2016

Venue:
Education Centre (Dept 17), The Christie, Manchester, M20 4BX

Course description:

The day will provide an update on changing treatment modality and toxicity management for lung cancer. We will discuss personalised medicine including immune therapy and future treatment options.

The Christie is one of Europe's leading experimental cancer medicine centres and an international leader in research and development.

This study day will look at the changing treatment modality and toxicity management for lung cancer and will use case studies to discuss how recent breakthroughs can benefit patient outcomes. Trial results will be discussed however the focus of the day will be on clinical outcomes and is relevant to a wide audience including Nurses, AHPs, GPs, medical staff & clinical research teams

Target Audience:

Nurses, AHPs, GPs, medical staff & clinical research teams

Course fee:

£90